Search Results - "NICHOLS, W. Garrett"

The impact of cytomegalovirus serostatus of donor and recipient before hematopoietic stem cell transplantation in the era of antiviral prophylaxis and preemptive therapy by Boeckh, Michael, Nichols, W. Garrett

“…In the current era of effective prophylactic and preemptive therapy, cytomegalovirus (CMV) is now a rare cause of early mortality after hematopoietic stem cell…”
Get full text

Dolutegravir efficacy at 48 weeks in key subgroups of treatment-naive HIV-infected individuals in three randomized trials by Raffi, François, Rachlis, Anita, Brinson, Cynthia, Arasteh, Keikawus, Górgolas, Miguel, Brennan, Clare, Pappa, Keith, Almond, Steve, Granier, Catherine, Nichols, W Garrett, Cuffe, Robert Liam, Jr, Joseph Eron, Walmsley, Sharon

“…OBJECTIVES:Dolutegravir (DTG) has been studied in three trials in HIV treatment-naive participants, showing noninferiority compared with raltegravir (RAL), and…”
Get full text

Respiratory Viruses Other than Influenza Virus: Impact and Therapeutic Advances by NICHOLS, W. Garrett, PECK CAMPBELL, Angela J, BOECKH, Michael

“…Classifications Services CMR Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text

Optimization of Quantitative Detection of Cytomegalovirus DNA in Plasma by Real-Time PCR by BOECKH, Michael, MEEILI HUANG, FERRENBERG, James, STEVENS-AYERS, Terry, STENSLAND, Laurence, NICHOLS, W. Garrett, COREY, Lawrence

“…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Influenza Infections after Hematopoietic Stem Cell Transplantation: Risk Factors, Mortality, and the Effect of Antiviral Therapy by Nichols, W. Garrett, Guthrie, Katherine A., Corey, Lawrence, Boeckh, Michael

“…Background. Community-acquired respiratory viruses, such as influenza virus, are thought to be major causes of morbidity and mortality in patients who had…”
Get full text

Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants by Marr, Kieren A., Crippa, Fulvio, Leisenring, Wendy, Hoyle, Maggie, Boeckh, Michael, Balajee, S. Arunmozhi, Nichols, W. Garrett, Musher, Benjamin, Corey, Lawrence

“…Prophylactic fluconazole prevents candidiasis; however, this drug has no activity against molds. We performed a randomized trial to determine whether…”
Get full text

High Risk of Death Due to Bacterial and Fungal Infection among Cytomegalovirus (CMV)—Seronegative Recipients of Stem Cell Transplants from Seropositive Donors: Evidence for Indirect Effects of Primary CMV Infection by Nichols, W. Garrett, Corey, Lawrence, Gooley, Ted, Davis, Chris, Boeckh, Michael

“…The impact of cytomegalovirus (CMV) serostatus (seropositive [+] or seronegative [-]) of the donor (D) and recipient (R) on mortality after allogeneic non-T…”
Get full text

Airflow Decline after Myeloablative Allogeneic Hematopoietic Cell Transplantation: The Role of Community Respiratory Viruses by Erard, Veronique, Chien, Jason W., Kim, Hyung W., Nichols, W. Garrett, Flowers, Mary E., Martin, Paul J., Corey, Lawrence, Boeckh, Michael

“…We conducted a 12-year retrospective study to determine the effects that the community respiratory-virus species and the localization of respiratory-tract…”
Get full text

Brief communication : Fatal human metapneumovirus infection in stem-cell transplant recipients by ENGLUND, Janet A, BOECKH, Michael, KUYPERS, Jane, NICHOLS, W. Garrett, HACKMAN, Robert C, MORROW, Rhoda A, FREDRICKS, David N, COREY, Lawrence, VAN BURIK, Jo-Anne H

“…Human metapneumovirus (hMPV), a recently discovered respiratory virus, is associated with clinical disease in young and elderly persons. To determine the…”
Get full text

Presentation of BK polyomavirus–associated hemorrhagic cystitis after allogeneic hematopoietic cell transplantation by Imlay, Hannah, Xie, Hu, Leisenring, Wendy M., Duke, Elizabeth R., Kimball, Louise E., Huang, Meei-Li, Pergam, Steven A., Hill, Joshua A., Jerome, Keith R., Milano, Filippo, Nichols, W. Garrett, Pang, Phillip S., Hirsch, Hans H., Limaye, Ajit P., Boeckh, Michael

“…BK polyomavirus (BKPyV) has been associated with hemorrhagic cystitis (HC) after allogeneic hematopoietic cell transplantation (HCT), but the natural history…”
Get full text

A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Oral Brincidofovir for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplantation by Marty, Francisco M., Winston, Drew J., Chemaly, Roy F., Mullane, Kathleen M., Shore, Tsiporah B., Papanicolaou, Genovefa A., Chittick, Greg, Brundage, Thomas M., Wilson, Chad, Morrison, Marion E., Foster, Scott A., Nichols, W. Garrett, Boeckh, Michael J.

“…•Prophylaxis with brincidofovir 100 mg twice weekly did not decrease clinically significant cytomegalovirus (CMV) infection (CMV disease or CMV DNAemia…”
Get full text

Safety and Tolerability of Oseltamivir Prophylaxis in Hematopoietic Stem Cell Transplant Recipients: A Retrospective Case-Control Study by Vu, Debie, Peck, Angela J., Nichols, W. Garrett, Varley, Cara, Englund, Janet A., Corey, Lawrence, Boeckh, Michael

“…Background. Oseltamivir is safe and effective in immunocompetent persons, and prophylactic use is recommended during influenza outbreaks. However, no data…”
Get full text

Parainfluenza virus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcome by Nichols, W. Garrett, Corey, Lawrence, Gooley, Ted, Davis, Chris, Boeckh, Michael

“…Parainfluenza virus (PIV) infections may be significant causes of morbidity and mortality in patients undergoing stem cell transplantation, but data regarding…”
Get full text

Airflow Obstruction after Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation by Chien, Jason W, Martin, Paul J, Gooley, Ted A, Flowers, Mary E, Heckbert, Susan R, Nichols, W. Garrett, Clark, Joan G

“…Despite advances in the management of myeloablative allogeneic hematopoietic stem cell transplants, airflow obstruction (AFO) remains a significant…”
Get full text

Short-term clinical safety profile of brincidofovir: A favorable benefit–risk proposition in the treatment of smallpox by Chittick, Greg, Morrison, Marion, Brundage, Thomas, Nichols, W. Garrett

“…Brincidofovir (BCV, CMX001) is an orally available, long-acting, broad-spectrum antiviral that has been evaluated in healthy subjects in Phase I studies and in…”
Get full text

Recent advances in the prevention of CMV infection and disease after hematopoietic stem cell transplantation by Boeckh, Michael, Fries, Bettina, Garrett Nichols, W.

“…:  Cytomegalovirus (CMV) remains an important pathogen in hematopoietic stem cell transplant (HCT) recipients in the current era of antiviral prophylaxis and…”
Get full text

Efficacy of transfusion with granulocytes from G-CSF/dexamethasone–treated donors in neutropenic patients with infection by Price, Thomas H., Boeckh, Michael, Harrison, Ryan W., McCullough, Jeffrey, Ness, Paul M., Strauss, Ronald G., Nichols, W. Garrett, Hamza, Taye H., Cushing, Melissa M., King, Karen E., Young, Jo-Anne H., Williams, Eliot, McFarland, Janice, Holter Chakrabarty, Jennifer, Sloan, Steven R., Friedman, David, Parekh, Samir, Sachais, Bruce S., Kiss, Joseph E., Assmann, Susan F.

“…High-dose granulocyte transfusion therapy has been available for 20 years, yet its clinical efficacy has never been conclusively demonstrated. We report here…”
Get full text

Valganciclovir for the prevention of complications of late cytomegalovirus infection after allogeneic hematopoietic cell transplantation: a randomized trial by Boeckh, Michael, Nichols, W Garrett, Chemaly, Roy F, Papanicolaou, Genovefa A, Wingard, John R, Xie, Hu, Syrjala, Karen L, Flowers, Mary E D, Stevens-Ayers, Terry, Jerome, Keith R, Leisenring, Wendy

“…Optimal prevention of late cytomegalovirus (CMV) disease is poorly defined. To compare valganciclovir prophylaxis with polymerase chain reaction-guided…”
Get full text

Fosamprenavir/ritonavir in advanced HIV disease (TRIAD): a randomized study of high-dose, dual-boosted or standard dose fosamprenavir/ritonavir in HIV-1-infected patients with antiretroviral resistance by Molina, Jean-Michel, Ait-Khaled, Mounir, Rinaldi, Roberto, Penco, Giovanni, Baril, Jean-Guy, Cauda, Roberto, Soriano, Vicente, Pialoux, Gilles, Wire, Mary Beth, Lou, Yu, Givens, Naomi, Craig, Charles, Nichols, W. Garrett, Barbosa, Inês, Yeo, Jane

“…Background APV102002 was an open-label study comparing a dual-boosted HIV-1 protease inhibitor (PI) [fosamprenavir/lopinavir/ritonavir (FPV/LPV/RTV; 1400…”
Get full text

Exebacase in Addition to Standard-of-Care Antibiotics for Staphylococcus aureus Bloodstream Infections and Right-Sided Infective Endocarditis: A Phase 3, Superiority-Design, Placebo-Controlled, Randomized Clinical Trial (DISRUPT) by Fowler, Vance G, Das, Anita F, Lipka-Diamond, Joy, Ambler, Jane E, Schuch, Raymond, Pomerantz, Roger, Cassino, Cara, Jáuregui-Peredo, Luis, Moran, Gregory J, Rupp, Mark E, Lachiewicz, Anne M, Kuti, Joseph L, Wise, Robert A, Kaye, Keith S, Zervos, Marcus J, Nichols, W Garrett

“…Abstract Background Novel treatments are needed for Staphylococcus aureus bacteremia, particularly for methicillin-resistant S. aureus (MRSA). Exebacase is a…”
Get full text